O objetivo deste estudo foi avaliar o perfil proteico do plasma seminal equino utilizando eletroforese bidimensional de gel de acrilamida (2D-PAGE) e determinar se algumas das proteínas presentes estavam relacionadas com a congelabilidade do sêmen. O plasma seminal foi coletado de dez garanhões, de alta e baixa congelabilidade de sêmen, provenientes do Haras Estatal da Baixa Saxônia, na cidade de Celle, na Alemanha e rotineiramente utilizados em programas de inseminação artificial. Vinte e cinco bandas proteicas foram encontradas nos géis bidimensionais (12%) e sete delas foram identificadas por MALDI-MS. Das 25 proteínas encontradas nas amostras de plasma seminal dos garanhões, duas bandas proteicas apresentaram densidade óptica superior (P<0,05) nas amostras de garanhões de alta congelabilidade o sêmen: as bandas 5 (80-85 kDa, pI 7,54), que foi identificada como CRISP3 e a 45 (18,2 kDa, pI 5,0-5,2) identificada como HSP-2. Contrariamente a banda 7 (75,4 kDa, pI 6,9 – 7,4), identificada como lactoferrina, a 15 (26,7 kDa, pI 5,51) identificada como calicreína, a 25 (25 kDa, pI 7,54) como CRISP3 e a 35 (13,9 kDa, pI 3,8 – 4,2) que foi identificada como HSP-1, apresentaram valores de densidade óptica superior (P<0,05) nos reprodutores de baixa congelabilidade do sêmen. As proteínas foram identificadas através de espectometria de massa MALDI-MS. As evidências encontradas neste experimento mostram que existem diferenças no perfil proteico dos reprodutores de alta e baixa congelabilidade do sêmen, sugerindo as proteínas CRISP3 e a HSP-2 como possíveis marcadores da alta congelabilidade de sêmen de garanhões. / The objective of this study was to evaluate protein profile of equine seminal plasma using two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and to find if any of these proteins were related to semen freezability. Seminal plasma was collected from 10 stallions of high and low semen freezability routinely used in AI programs from the State Stud of Lower Saxony and Artificial Insemination Center. Twenty five protein spots were identified from the 2 D gel (12%), seven of which were present in all samples. Of the 25 proteins found in the research stallions, two spots showed superior relative content (P<0.05) in seminal plasma samples collected from stallions with high semen freezability: the spots 5 (80-85 kDa, pI 7.54) was identified as CRISP3 and 45 (18.2 kDa, pI 5.0-5.2) was identified as HSP-2. Conversely, the spot 7 (75.4 kDa, pI 6.9 – 7.4) was identified as lactoferrin, 15 (26.7 kDa, pI 5.51) was identified as kallikrein, 25 (25 kDa, pI 7.54) was identified as CRISP3 and 35 (13.9 kDa, pI 3.8 – 4.2) was identified as HSP-1, showed superior relative protein content (P<0.05) on seminal plasma samples from stallions with low semen freezability. The proteins were identified by MALDI-MS. There were differences in the seminal plasma protein profile between stallions with high and low semen freezability. It may be suggested that CRISP3 and HSP-2 may be considered possible seminal plasma markers of high semen freezability.

INTRODUÇÃO: A lactoferrina disponível no leite materno desempenha função imunológica e protege recém-nascidos de infecções por se ligar ao ferro e privá-lo de bactérias patogênicas, o que resulta em atividade bacteriostática contra organismos patogênicos ferro dependentes. A utilização de aditivo de leite materno suplementado com ferro poderia prejudicar os efeitos protetores da lactoferrina e aumentar os riscos de infecção em recém-nascidos. OBJETIVO: Comparar o crescimento bacteriano no colostro puro versus colostro com aditivo de leite materno suplementado com ferro. MÉTODO: O crescimento bacteriano de Escherichia coli, Staphylococcus aureus e Pseudomonas aeruginosa foi comparado em 78 amostras de colostro puro ou colostro com aditivo do leite humano suplementado com ferro. Para análise qualitativa, discos de papel filtro foram imergidos nas amostras de leite materno puro ou leite materno com aditivo suplementado de ferro e incubados por 48 horas em placas de Petri contendo 101 Unidades Formadoras de Colônia por ml (UFC/ml) de cada cepa de bactérias. Para a análise quantitativa, 1ml de cada cepa de bactérias contendo 107 UFC/ml foi homogeneizado com 1ml de colostro puro ou colostro com aditivo do leite humano suplementado com ferro e semeado em placa de Petri. O número de UFC/ml foi contado após 24 horas de incubação a 37oC. RESULTADOS: A análise qualitativa não mostrou diferença no crescimento bacteriano. Na avaliação quantitativa, o crescimento de Escherichia coli no colostro puro foi de 29.4 ± 9.7 x 106CFU/ml e no colostro com aditivo de leite materno suplementado de ferro foi de 31.2 ± 10.8x 106CFU/ml, com diferença na média de crescimento de 1.9 ± 4.9 x 106CFU/ml (p = 0,001). O crescimento bacteriano nas cepas de Staphylococcus aureus e Pseudomonas aeruginosa no colostro puro e no colostro com aditivo de leite materno não apresentou diferença estatística. CONCLUSÃO: O acréscimo de aditivo de leite materno suplementado com ferro nesta concentração reduziu a ação bacteriostática contra Escherichia coli / BACKGROUND: Lactoferrin in human breast milk has been shown to protect newborns from infection by binding to iron and depriving it from pathologic bacteria that need iron to proliferate. If iron-enriched fortifier is added to breast milk, it might impair the protective effect of lactoferrin and increase the risk of infection in newborns. OBJECTIVE: To compare bacterial growth in pure colostrum versus colostrum with human milk fortifier containing iron. METHODS: The growth of Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa in 78 samples of pure colostrum or of colostrum with added human milk fortifier containing iron was compared. For qualitative analysis, filter paper discs were immersed in samples from each group and incubated for 48 hours with 101Colony Forming Units/ml of each strain. For quantitative assessment, 1 ml of each strain containing 107Colony Forming Units/ml was homogenized with 1 ml of either colostrum or colostrum with human milk fortifier, seeded into a Petri dish, and incubated at 37oC. Twenty-four hours later the number of Colony Forming Units was counted. RESULTS: Qualitative analysis showed no difference in bacterial growth. In the quantitative evaluation, Escherichia coli growth in the pure colostrum group was 29.4 ± 9.7 x 106CFU/ml while in the human milk fortifier group it was 31.2 ± 10.8x 106CFU/ml; the difference between average growth was 1.9 ± 4.9 x 106CFU/ml (p = 0.001). There were no differences in Staphylococcus aureus and Pseudomonas aeruginosa growth. CONCLUSION: Addition of iron at this concentration reduced breast milk bacteriostatic action against Escherichia coli

Bovine lactoferrin (BLF) and bovine transferrin (BTF) are major-iron transport and regulation proteins found in bovine whey. BLF and BTF must interact with the eukaryotic cell surface to mediate their biological function of iron delivery and cellular functions of inflammatory and immunological modulation. As common components of the eukaryotic cell surface, gangliosides were used for affinity purification of BLF and BTF. Bovine gangliosides were isolated from fresh buttermilk and covalently immobilized onto controlled-pore glass beads (66 μg/g beads). After the matrix was loaded with whey protein (WPI or WPC), lactoferrin was eluted with 1 M NaCl and lll identified by N-terminal protein sequencing. Pretreated whey isolate (1 % wt/vol) showed the highest lactoferrin purity with 40% among protein sources, and whey protein isolate (10% wt/vol) showed the highest recovery with 105%. Bovine transferrin was eluted with sodium phosphate buffers at pH 7 after the immobilized matrix was loaded with a 2% (wt/vol) whey solution. The ganglioside column resulted in a 74.2% recovery of BTF from whey, and the BTF was enriched to 61% purity after Mono-Q chromatography. Bovine transferrin was identified by SDS-PAGE analysis, Western analysis, and isoelectrofocusing. In conclusion, immobilized gangliosides can be used to purify BLF and BTF from bovine whey.

Methods for on-farm extraction of low-concentration (minor) proteins from raw whole bovine milk directly after milking were explored. These minor proteins have high commercial value. Lactoferrin (LF) and lactoperoxidase (LP) were used as model proteins for extraction using cation exchange chromatography. Laboratory fractionations showed that milk could be processed by conventional column chromatography without excessive column backpressures if resin with large particles sizes were used and the temperature was high enough so fat in the milk was malleable; ideally the milk should be near the secretion temperature of 37oC. Processing parameters such as equilibrium and dynamic capacities were determined for SP Sepharose ™ (GE Healthcare Technologies) and Bio Rex 70 (BioRad Laboratories) resins. SP Sepharose Big Beads (SP BB) were found to be more suitable than BR 70, for raw whole milk processing due to the larger size (200 um). Design considerations showed that column chromatography was not the most practical method for on-farm processing of fresh, raw whole milk. Trials with a single-stage stirred tank showed that SP BB resin could extract up to 65% of LF (initial LF concentration of 0.5 mg/mL) with a 10-minute adsorption time. The composite non-linear (CNL) model of Rowe et al. (1999) was used to describe LF uptake by SP BB resin in raw whole milk with initial LF concentrations of 0 to 1.0 mg/mL and resin:milk volume ratios of 0.010, 0.012, 0.017 and 0.024 over 45-minute contact times. The CNL model could be used to predict LF yields if initial feed concentration, milk and resin volumes, and contact times were known. Laboratory extractions showed that processing did not significantly affect bulk milk composition (fat, protein, lactose and total solids), indicating that the milk could be used for conventional processing after the minor proteins had been extracted. Resin cleaning and regeneration studies, using a procedure similar to that recommended by the resin supplier, showed that the Sepharose resin had not degraded and there was no significant decrease in binding capacity after 50 extraction cycles. A Protein Fractionation Robot (PFR) prototype based on a single-stage stirred tank and the operating parameters obtained from the laboratory trials was designed, assembled and coupled to an Automated Milking System (AMS) to process fresh, raw whole milk from individual cows immediately after milking. The LF and LP extracted from the milk from 16 individual cows were 19.7 - 55.2% (35.6 10.2%) and 21.2 - 99.5% (87.1 12.0%) respectively. Generally, higher extraction levels were obtained at higher resin:milk ratios. The amount of LF extracted on-farm agreed within 14.1 9.8% of those predicted by the CNL model, with predicted values generally being higher. The experimental on-farm adsorption values were calculated using data of LF recovered after elution, so differences between actual and predicted values may be due to losses during post-adsorption processing. Economic feasibility studies, based on experimental data from the PFR and realistic wholesale prices for LF and LP ($400 and $150/kg respectively) showed that PFR-based processing is economically viable if the farmer is paid for the LF and LP produced as well as the bulk milk. This system would have a payback period of approximately five years and an internal rate of return of 14.5%. Further case studies determined the sensitivity of the economics to various operating parameters and value/cost assumptions, including producing recombinant human protein from transgenic bovine milk. These studies showed that the higher the value of the processed raw milk, the higher the absorptive capacity of the resin, and the higher the value of the extracted protein, the more favourable the economics. In the extreme case of producing a very high value therapeutic protein (e.g. $20 000), the payback period could be as low as 0.3 years, with an internal rate of return of 818%.

Cervical cancer is the second most common cancer among women worldwide and human papillomavirus (HPV) is a prerequisit for the development of this cancer. HPV belongs to the Papillomaviridae family and infects the basal layer of epithelial cells where it generally progresses into warts or condylomas. HPV can only reproduce in differentiating epithelia and it is therefore difficult to study the natural infection of HPV. More than 100 HPV types exist and they are divided into different genera based on their L1 open reading frame sequence. Most of the HPV types in the alpha-papillomavirus genus infect the mucosal epithelium while HPVs from the beta-papillomavirus genus usually infect cutaneous epithelial cells. Presently, it is not known what decides the anatomical tropism and our aim was to study determinants of this tropism. By using HPV virus like particles (VLP) and pseudovirus we found that VLPs from the two alpha-papillomaviruses HPV-6 and HPV-16 interacted with cell-surface heparan sulfate (HS) for initial attachment. When we labelled HPV VLPs with a fluorescent dye to study internalization HPV-6 was more strongly inhibited than HPV-16. Furthermore, a pseudovirus infection assay demonstrated that the beta-papillomavirus HPV-5 was less dependent on HS for infection than HPV-16. By analyzing the isoelectric point (p1) of the HPV L1 capsid protein we found that alpha HPV types were more positively charged than beta HPV types. Also, HPV-6 had a higher positive charge than HPV-16. Thus, the inhibition of the negatively charged heparin against HPV infection was clearly related to the charge of the HPV L1 capsid. This suggested that the initial interaction could be one of the determinants of tropism although not the sole factor. Lactoferrin is a protein found in milk, saliva, semen, tear fluid and endocervical secretions that has antiviral activities. Both human and bovine lactoferrin inhibited HPV infection but we found no significant differences in inhibition of alpha- and beta-papillomavirus infection. We could however demonstrate that different lactoferricins, small peptide derivates from the N-terminal part of lactoferrin, were able to inhibit HPV infection. This antiviral activity depended on lactoferricin peptide, HPV type and cell origin. The regulation of HPV gene expression in the host cell could also determine HPV tropism. The HPV long control region (LCR) contains cis-responsive elements that regulate HPV transcription and the epithelial tropism of HPV is determined by epithelial specific constitutive enhancers in the LCR. It has been hypothesized that the combination of transcription factors in the host cell determines the cell-type-specific expression. In cells with a skin origin the HPV-5 LCR was twice as efficient in transcriptional activation compared to HPV-16 LCR, while in cervical cells the HPV-16 LCR was almost twice as effective in activating transcription compared to HPV-5 LCR. To conclude, alpha- and beta-papillomaviruses differed regarding their ability to infect cells and regulate viral gene expression. These abilities corresponded with their natural host cells and suggested that HPV anatomical tropism could be determined at several steps in the HPV life cycle.

The adenovirus (Ad) family consists of 52 different human types, which are divided into seven species (A-G). Human Ads cause disease in the respiratory tract, lymphoid tissue, intestine, urinary tract, and/or in the eye. Most, but not all Ads have been demonstrated to use the coxsackie-adenovirus receptor (CAR) as an efficient receptor in vitro, but CAR has been questioned as an in vivo-receptor for various reasons. Thus, there are reasons to believe that Ads use other mechanisms for binding to target cells. In an attempt to investigate the impact of tear fluid during in vitro infection of ocular Ads (i.e. Ad37), using corneal cells, we found that human tear fluid promoted infection of an Ad with pronounced respiratory tropism (i.e. Ad5) used here as a control, but surprisingly not of Ad37. Furthermore using a virus overlay protein blotting assay we found that Ad5 bound to several tear fluid proteins. One of these, human lactoferrin (hLf) which is a component that belongs to the innate immune system in various body fluids, was alone able to promote both binding and infection of all species C Ads (Ad1, Ad2, Ad5, Ad6) in epithelial cells. hLf was also found to promote gene delivery (GFP) from an Ad5-based vector. Further we have identified lactoferricin (Lfcin), the N-terminal part of hLf, as to be responsible for this effect. We also show that plasma, saliva, and tear fluid promote infection of Ad5 in respiratory and ocular epithelial cells, and that plasma promotes infection of Ad31. The component in plasma that is responsible for this effect is likely to be coagulation factor IX (FIX) and X (FX), since both these factors were able to promote binding and infection of Ad5 and/or Ad31 in epithelial cells. Finally, we show that the excess of fiber production from initial Ad infection and the release of fibers before the particle itself is released caused masking of the tropism-specific receptors in both infected and non-infected surrounding cells. This means that the overproduction of fibers affects the ability of Ad to spread within tissues. We conclude that soluble components in body fluids, such as hLf, FIX, and FX have the ability to mediate binding and infection of selected human Ads (species C and Ad31) in epithelial cells that represent the tropism of these Ads. We suggest that these components may serve as bridges between the virion and the cell surface. This is contributes to the knowledge about Ad lifecycle, and might help to improve the de-/retargeting of gene therapy based on Ad vectors.

Universiẗat, Diss., 2004--München.

Thesis (M.S.)--Uniformed Services University of the Health Sciences, 2006 / Typescript (photocopy)

INTRODUCTION: The management of pediatric patients with ulcerative colitis (UC) is dependent upon the ability to detect meaningful changes in disease status. This is currently done using validated patient-reported clinical disease activity indices, including the Pediatric Ulcerative Colitis Activity Index (PUCAI). While useful for global assessments completed during ambulatory office visits, the sensitivity of this metric may be insufficient to reflect more subtle changes in disease activity or response to medical therapy in hospitalized patients. Intravenous steroids are typically employed in the management of patients admitted for acute exacerbations of UC symptoms. These are typically manifest by worsening bloody diarrhea, abdominal pain, and worsening anemia. There is presently no way of predicting whether a patient admitted for UC will respond to steroid therapy. Current paradigms dictate a five-day trial before considering a transition to more potent medical or definitive surgical approaches to the management of refractory colitis. The development of more sensitive and reliable biomarkers or disease activity metrics could enable clinicians to more expediently identify steroid non-responders. This would minimize patient morbidity, decrease risk of complication, and lower overall cost of care. Previous studies have demonstrated that changes in fecal lactoferrin (FLA) correlate with disease activity in patients with UC. OBJECTIVES: To analyze the predictive value of FLA in the response to steroid treatment of patients admitted for management of UC. METHODS: We recruited pediatric inpatients with UC in the Division of Gastroenterology, Hepatology and Nutrition at Boston Children’s Hospital who were hospitalized for treatment of a flare of their UC symptoms. After obtaining patient consent, we collected a stool sample on days 1 and 3 of their hospital stay. We sent samples to TECHLAB® Inc. (Blacksburg, VA) to be analyzed for levels of FLA. We compared Day 1, Day 3 and ∆FLA (Day 1 – Day 3) in two patient groups: those that responded to conventional steroid therapy and those that required rescue medical or surgical therapy. We reported statistical significance with the Wilcoxon signed-rank test. RESULTS: Of 67 patients consented for the study, 30 provided stool samples on both days 1 and 3 of their inpatient hospitalization. Of the 30 patients, 63.3% responded to steroids while 36.7% required rescue therapy with immunomodulators. ∆FLA for responders, 43.6μg/mL(-239.0, 331.6) (median(interquartile range)), did not differ significantly from non-responders, -74.1μg/mL(-296.7, 221.7), P = 0.3. CONCLUSIONS: Our findings do not demonstrate that measurement of changes in quantitative FLA over three days can be used to assess acute responses to steroid therapy. Increasing the sample size may allow us to better delineate subtle differences between responders and non-responders to steroid therapy.

O objetivo deste estudo foi avaliar o perfil proteico do plasma seminal equino utilizando eletroforese bidimensional de gel de acrilamida (2D-PAGE) e determinar se algumas das proteínas presentes estavam relacionadas com a congelabilidade do sêmen. O plasma seminal foi coletado de dez garanhões, de alta e baixa congelabilidade de sêmen, provenientes do Haras Estatal da Baixa Saxônia, na cidade de Celle, na Alemanha e rotineiramente utilizados em programas de inseminação artificial. Vinte e cinco bandas proteicas foram encontradas nos géis bidimensionais (12%) e sete delas foram identificadas por MALDI-MS. Das 25 proteínas encontradas nas amostras de plasma seminal dos garanhões, duas bandas proteicas apresentaram densidade óptica superior (P<0,05) nas amostras de garanhões de alta congelabilidade o sêmen: as bandas 5 (80-85 kDa, pI 7,54), que foi identificada como CRISP3 e a 45 (18,2 kDa, pI 5,0-5,2) identificada como HSP-2. Contrariamente a banda 7 (75,4 kDa, pI 6,9 – 7,4), identificada como lactoferrina, a 15 (26,7 kDa, pI 5,51) identificada como calicreína, a 25 (25 kDa, pI 7,54) como CRISP3 e a 35 (13,9 kDa, pI 3,8 – 4,2) que foi identificada como HSP-1, apresentaram valores de densidade óptica superior (P<0,05) nos reprodutores de baixa congelabilidade do sêmen. As proteínas foram identificadas através de espectometria de massa MALDI-MS. As evidências encontradas neste experimento mostram que existem diferenças no perfil proteico dos reprodutores de alta e baixa congelabilidade do sêmen, sugerindo as proteínas CRISP3 e a HSP-2 como possíveis marcadores da alta congelabilidade de sêmen de garanhões. / The objective of this study was to evaluate protein profile of equine seminal plasma using two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and to find if any of these proteins were related to semen freezability. Seminal plasma was collected from 10 stallions of high and low semen freezability routinely used in AI programs from the State Stud of Lower Saxony and Artificial Insemination Center. Twenty five protein spots were identified from the 2 D gel (12%), seven of which were present in all samples. Of the 25 proteins found in the research stallions, two spots showed superior relative content (P<0.05) in seminal plasma samples collected from stallions with high semen freezability: the spots 5 (80-85 kDa, pI 7.54) was identified as CRISP3 and 45 (18.2 kDa, pI 5.0-5.2) was identified as HSP-2. Conversely, the spot 7 (75.4 kDa, pI 6.9 – 7.4) was identified as lactoferrin, 15 (26.7 kDa, pI 5.51) was identified as kallikrein, 25 (25 kDa, pI 7.54) was identified as CRISP3 and 35 (13.9 kDa, pI 3.8 – 4.2) was identified as HSP-1, showed superior relative protein content (P<0.05) on seminal plasma samples from stallions with low semen freezability. The proteins were identified by MALDI-MS. There were differences in the seminal plasma protein profile between stallions with high and low semen freezability. It may be suggested that CRISP3 and HSP-2 may be considered possible seminal plasma markers of high semen freezability.